Paragraph IV Challenges
| Tradename | Dosage | Generic Name | NDA | ANDAs Submitted | 180 Day Exclusivity Status | Submissiondate |
|---|---|---|---|---|---|---|
| MEKINIST | Tablets | trametinib dimethyl sulfoxide | 204114 | 1 | 2026-08-31 | |
| ZEPBOUND KWIKPEN | Subcutaneous Solution | tirzepatide | 217806 | 1 | 2026-08-26 | |
| MOUNJARO KWIKPEN | Subcutaneous Solution | tirzepatide | 215866 | 1 | 2026-08-24 | |
| ZEPBOUND KWIKPEN | Subcutaneous Solution | tirzepatide | 217806 | 1 | 2026-08-24 | |
| KOSELUGO | Capsules | selumetinib sulfate | 213756 | 1 | 2026-08-04 | |
| TONMYA | Sublingual Tablets | cyclobenzaprine hydrochloride | 219428 | 1 | 2026-07-29 | |
| >Tradename | >Dosage | >Generic Name | >NDA | >ANDAs Submitted | >180 Day Exclusivity Status | >Submissiondate |
